Structural and functional study of K453E mutant protective protein/cathepsin A causing the late infantile form of galactosialidosis
Abstract
To clarify the molecular basis of the late infantile form of galactosialidosis, we characterized a defective protective protein/cathepsin A (PPCA) gene product with the K453E mutation newly found in an Arabic patient with this disease. Immunocytochemical, expression, and metabolic studies revealed that the precursor PPCA was synthesized but not processed to the mature form, and it was degraded in the mutant. A structural model of the mutant PPCA was constructed by amino acid substitution of 453glutamic acid for lysine in the crystal structure of the wild type PPCA precursor reported. The results show that the K453E mutation is located at the dimer interface of the PPCA and reduces the hydrogen bond formation in the dimer. This structural change may cause instability of the PPCA dimer.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The most heterogeneous pool of CTSA mutations has been found in patients with the severe, early infantile form of GS, although some recurrent mutations point to a founder effect in specific ethnic groups.
“As foreseeable, the most heterogeneous pool of CTSA mutations have been found in patients with the severe, early infantile form of GS, although some recurrent mutations seem to point to a founder effect in specific ethnic groups 20–23.”
From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [20]
There is a strong correlation between the type and combination of amino acid substitutions and the clinical outcome in GS.
“In general, we can assert that there is a strong correlation between the type and combination of amino acid substitutions and the clinical outcome.”
From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [20]
Late infantile GS is characterized by two recurrent missense mutations, Phe458Val and Tyr267Asn, that appear pathognomonic for this clinical phenotype.
“Instead, the group of patients with the late infantile form of the disease is characterized by two recurrent, missense mutations, resulting in two amino acid substitutions, Phe458Val and Tyr267Asn, that appear to be pathognomonic for this clinical phenotype.”
From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [20]
The majority of CTSA mutations reported in the literature have been identified in Japanese patients, who share a common single base substitution at the donor splice site of intron 7 causing skipping of exon 7 (SpDEx7), and this mutation apparently segregates with the juvenile/adult type.
“By far, the majority of CTSA mutations reported in the literature have been identified in Japanese patients 8,20,21.”
From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [20]
Cited by
Sorted by citations
Galactosialidosis: review and analysis of CTSA gene mutations
Caciotti, A., Catarzi, S., Tonin, R., Lugli, L., Perez, C. R., Michelakakis, H., Mavridou, I., Donati, M. A., Guerrini, R., d’Azzo, A., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-114 · Cited by 73 · see citing works
Galactosialidosis: historic aspects and overview of investigated and emerging treatment options
Annunziata, I., & d’Azzo, A. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1266933 · Cited by 50 · see citing works
- Authors
- Takiguchi, K., Itoh, K., Shimmoto, M., Ozand, P. T., Doi, H., & Sakuraba, H.
- Affiliations
- Fujitsu (Japan) (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- King Faisal Specialist Hospital & Research Centre (SA)
- Venue
- Journal of Human Genetics
- Published
- 2000-07
- Volume
- 45
- Issue
- 4
- Pages
- 200-206
- ISSN
- 1434-5161 (ISSN-L)
- 1435-232X
- OpenAlex
- W2029520951
- Cited by
- 17
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 2
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tokyo Metropolitan Government
- Topics
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
- Keywords
- galactosialidosis, lysosomal storage disease, protein dimer stability, dimer interface, protein degradation, crystal structure model, lysosomal enzymes
- MeSH terms
- beta-Galactosidase, Carboxypeptidases, Child, Female, Humans, Immunohistochemistry, Lysine, Metabolism, Inborn Errors, Models, Molecular, Neuraminidase, Blotting, Northern, Crystallography, X-Ray, Glutamic Acid, Amino Acid Substitution, Mutation, Missense, Protein Structure, Quaternary, Cathepsin A, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review